A study of major US private payers showed an important role and considerable shortcomings of external health technology assessment in coverage decisions on personalized medicine. We reviewed 7 HTA ...
A white paper published by the Institute for Clinical and Economic Review (ICER) established a series of recommendations and guidelines for health technology assessment that aim to address health care ...
This article is part of a Health Affairs Forefront short series, “Enhancing Value By Evaluating Health Care Services.” The series discusses ways to extend the use of tools for clinical and economic ...
Analyze what evidence is required for HTA evaluations to show that a particular drug/medtech product represents an improvement on current practice. Gain an insight into HTA programs & identify common ...
In today's rapidly evolving healthcare landscape, health technology assessment (HTA) agencies face a difficult challenge: keeping up with the fast-paced development of innovative technologies.
New regulations have marked a significant shift in how health technology assessments are conducted across the EU, but its effects will not be felt overnight. As implementation rolls out in stages ...
Health technology assessment (HTA) plays an increasing role in translating emerging technologies into clinical practice and policy. Private payers are important users of HTA whose decisions impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback